Zobrazení zdroje stránky Sejersenhaaning1821

Electronic health records are becoming increasingly common tools for storing and sharing patient health information. Many vendors offer patient "portals" as a way for patients and/or proxies to view test results and communicate with their health care teams. Few researchers have looked at patient portals in the inpatient pediatric population. Our objectives were to describe portal activation and use and factors associated with these end points for hospitalized children.<br /><br /> Retrospective, single-center study of pediatric patients birth through 17 years old who had at least one hospital admission and one or more inpatient diagnostic test performed between January 1, 2018, to December 31, 2018. Portal use was defined as viewing one or more test result. Multivariate logistic regression analyzed the association between patient characteristics and portal account activation and use.<br /><br /> A total of 5862 patients with 170 685 diagnostic test results were included. [https://www.selleckchem.com/products/bgb-290.html Selleckchem Pamiparib] A total of 40.9% of patients had an activated account, and 20.3% viewed one or more test result. Factors associated with an increased odds of portal activation and/or use included English as preferred language, white race, commercial insurance, multiple admissions, previous outpatient testing, and having both laboratory and imaging inpatient studies performed.<br /><br /> In this study, we highlight the underuse of the patient portal in the inpatient pediatric population, especially for patients whose preferred language is not English, self-identify as multiracial and are publicly insured or uninsured. Concerted efforts to eliminate health care disparities in relation to portal activation are needed.<br /><br />In this study, we highlight the underuse of the patient portal in the inpatient pediatric population, especially for patients whose preferred language is not English, self-identify as multiracial and are publicly insured or uninsured. Concerted efforts to eliminate health care disparities in relation to portal activation are needed.<br /><br /> Early diagnosis is key to improve cancer outcomes, and most cancers are diagnosed in primary care after initial symptomatic presentation. Emerging evidence suggests an increase in avoidable cancer deaths owing to the COVID-19 pandemic.<br /><br /> To understand GPs' views on the impact of the COVID-19 pandemic on the clinical assessment of possible cancer.<br /><br /> A qualitative semi-structured interview study with GPs from the East of England.<br /><br /> GPs were purposively sampled based on age, sex, and years of experience. Interviews were conducted via Zoom or Microsoft Teams in August and September 2020. Transcribed recordings were analysed inductively using thematic analysis. The Model of Pathways to Treatment guided the analysis.<br /><br /> Three themes were identified across 23 interviews on GP views on the impact of (1) changes in patient help-seeking behaviour on symptoms at presentation; (2) remote consultations on managing patients with possible cancer symptoms; and (3) the COVID-19 pandemic on triaging and referring patients with possible cancer. There were positive changes to practice, but concerns were raised about the adequacy of remote consultations for assessing symptoms. Some GPs reported delayed cancer diagnoses, and uncertainty about how backlog in referrals would be managed.<br /><br /> This study provides new evidence on the impact of the COVID-19 pandemic on assessing symptomatic patients. Recommendations are made to inform safe and effective primary care clinical practice. Urgent action is needed to mitigate the impact of the COVID-19 pandemic, and ensure appropriate symptomatic assessment now and in the future.<br /><br />This study provides new evidence on the impact of the COVID-19 pandemic on assessing symptomatic patients. Recommendations are made to inform safe and effective primary care clinical practice. Urgent action is needed to mitigate the impact of the COVID-19 pandemic, and ensure appropriate symptomatic assessment now and in the future.<br /><br /> General practices in England have continued to care for patients throughout the COVID-19 pandemic by instigating major changes to service delivery. Immunisations have continued, although the number of vaccines delivered initially dropped in April 2020.<br /><br /> To evaluate how COVID-19 impacted the delivery of immunisations in London and identify innovative practices to inform future delivery, including for COVID-19 vaccines.<br /><br /> A mixed-methods study of immunisation delivery in London, UK.<br /><br /> An online survey of London general practices was undertaken in May 2020 to produce a descriptive analysis of childhood immunisation delivery and identify innovative delivery models. Semi-structured interviews were conducted between August and November 2020 to explore innovative immunisation models, which were analysed thematically.<br /><br /> Sixty-eight per cent (<br /><br /> = 830) of London practices completed the survey and 97% reported having continued childhood immunisation delivery. Common delivery adaptations included spaced-out appointmed by building on existing local knowledge, experiences, and networks. Immunisation delivery during the pandemic, including for COVID-19 vaccines, should be tailored to local population needs by building on primary care immunisation expertise.<br /><br /> Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody testing in community settings may help us better understand the immune response to this virus and, therefore, help guide public health efforts.<br /><br /> To conduct a seroprevalence study of immunoglobulin G (IgG) antibodies in Irish GP clinics.<br /><br /> Participants were 172 staff and 799 patients from 15 general practices in the Midwest region of Ireland.<br /><br /> This seroprevalence study utilised two manufacturers' point-of-care (POC) SARS-CoV-2 immunoglobulin M (IgM)-IgG combined antibody tests, which were offered to patients and staff in general practice from 15 June to 10 July 2020.<br /><br /> IgG seroprevalence was 12.6% in patients attending general practice and 11.1% in staff working in general practice, with administrative staff having the lowest seroprevalence at 2.5% and nursing staff having the highest at 17.6%. Previous symptoms suggestive of COVID-19 and history of a polymerase chain reaction (PCR) test were associated with higher seroprevalence. IgG antibodies were detected in approximately 80% of participants who had a previous PCR-confirmed infection.